In order to develop an experimental DNA Vaccine for the prevention and trea
tment of hepatitis B virus infection, hepatitis B virus surface antigen (HB
sAg) DNA was subcloned into an E. coli-eukaryotic cell shuttle vector and w
as expressed in the Baculovirus expression system. Intramuscular, intraderm
al, and intraperitoneal injections of 30 mu g of the plasmid DNA expressing
HBsAg induced humoral and cellular immune responses in ICR mice. The first
IgG antibodies were detected after ten days and specific IgG antibody tite
rs peaked after two months of a single intramuscular DNA injection. Anti-HB
s antibody titers gradually increased and peaked at four months following i
ntradermal DNA injection, and in case of intraperitoneal injection they pea
ked at seven months. Generation of HBs-specific helper T lymphocytes was al
so investigated through the production of interleukin-2 by T helper cells.
Boosting effects of HBs DNA were investigated without much results. In gene
ral, DNA-mediated HBs immunization induced humoral and cellular immune resp
onses in mice that appears to simulate immune responses in human during the
course of HBV vaccination.